Also one other point nobody seems to recall about

Also one other point nobody seems to recall about EUA's...."safe and maybe effective...and NO already approved AlTERNATIVE". Nowthere is no alternative for decreased mortality in critical patients but that is no longer our endpoint...our endpoint is now decreasing length of hospital stay and as you will recall remdesivir is now FULLY approved with an indication of dec. length of stay in ALL hospitalized patients...they very endpoint the FDA gave us...Wonder why that is??? Bc now we can't get an EUA... Our only path to market is FULL approval which is a much harder and higher bar to meet which takes a lot more time for review.